DYADIC INTERNATIONAL INC Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss
DYADIC INTERNATIONAL INC (DYAI) had Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss of $1.25 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss · last filed 2026-08-12
- 2026-06-30: Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss $1.25K.
- 2026-03-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss $992.00.
- 2025-12-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss $290.00.
- 2025-06-30: Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss $1.32K.
| Period end | Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss |
|---|---|
| 2026-06-30 | $1.25K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $992.00 10-Q · filed 2026-05-13 |
| 2025-12-31 | $290.00 10-Q · filed 2026-08-12 |
| 2025-06-30 | $1.32K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $382.00 10-Q · filed 2025-05-14 |
| 2024-12-31 | $149.00 10-K · filed 2026-03-25 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 |
| 2024-06-30 | $2.22K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $930.00 10-Q · filed 2024-05-14 |
| 2023-12-31 | $185.00 10-K · filed 2025-03-26 |
| 2023-09-30 | $321.00 10-Q · filed 2023-11-08 |
| 2023-06-30 | $4.33K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $24.12K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $47.21K 10-K · filed 2024-03-28 |
| 2022-09-30 | $63.98K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $52.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $17.76M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $2.50K 10-K · filed 2023-03-29 |
| 2021-09-30 | $7.79K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $11.58K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $17.85K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $6.46K 10-K · filed 2022-03-29 |
| 2019-12-31 | $17.99K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |